Cargando…
S1P signaling: new therapies and opportunities
Development of sphingosine-1-phosphate receptor 1 (S1P(1)) modulators to dampen inflammation and its sequelae is becoming increasingly promising for treating medical conditions characterized by significant immunopathology. As shown by the non-selective S1P receptor modulator FTY720 (fingolimod [Gile...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Faculty of 1000 Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251414/ https://www.ncbi.nlm.nih.gov/pubmed/25580263 http://dx.doi.org/10.12703/P6-109 |